Thanks for alerting us to this trial Upmarket and
for trial details jcurve.
”The (pilot) study outcomes revealed oral PPS
significantly improved pain, stiffness and other
functional measures in these patients”.
We have been led to believe that oral PPS
is virtually useless for OA treatment.
If that is true, why is David Hunter (of all
people) involved with this study. Just for
”shits and giggles” or waste some money.
As I understand it, PAR has no patents or
agreement with Bene to trial or market the
oral version of PPS.
General OA media and info, page-222
-
- There are more pages in this discussion • 449 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.020(8.33%) |
Mkt cap ! $90.94M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 26.0¢ | 24.5¢ | $195.9K | 781.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 38000 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 102892 | 9 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |